These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18383596)

  • 21. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia.
    Cau M; Loi M; Melis M; Congiu R; Loi A; Meloni C; Serrenti M; Addis M; Melis MA
    Eur J Med Genet; 2009; 52(5):344-8. PubMed ID: 19454328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
    Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
    Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel CCM1 gene mutation causes cerebral cavernous malformation in a Chinese family.
    Zhao Y; Xie L; Li P; Song J; Qu T; Fan W; Chen H; Chen D; Lu D; Zhou L; Mao Y
    J Clin Neurosci; 2011 Jan; 18(1):61-5. PubMed ID: 20884211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperkeratotic cutaneous vascular malformation associated with familial cerebral cavernous malformations (FCCM) with KRIT1/CCM1 mutation.
    Feldmeyer L; Baumann-Vogel H; Tournier-Lasserve E; Riant F; Jung HH; French LE; Kamarashev J
    Eur J Dermatol; 2014; 24(2):255-7. PubMed ID: 24721395
    [No Abstract]   [Full Text] [Related]  

  • 25. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.
    Laberge-le Couteulx S; Jung HH; Labauge P; Houtteville JP; Lescoat C; Cecillon M; Marechal E; Joutel A; Bach JF; Tournier-Lasserve E
    Nat Genet; 1999 Oct; 23(2):189-93. PubMed ID: 10508515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent insights into cerebral cavernous malformations.
    Faurobert E
    FEBS J; 2010 Mar; 277(5):1069. PubMed ID: 20096039
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebral cavernous malformations: mutations in Krit1.
    Verlaan DJ; Davenport WJ; Stefan H; Sure U; Siegel AM; Rouleau GA
    Neurology; 2002 Mar; 58(6):853-7. PubMed ID: 11914398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
    Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
    Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel KRIT1 gene mutation in a patient with cerebral and multiple spinal cavernous malformations.
    Lee YW; Lee ST; Cha JG; Park JH; Jeon BR; Lee YK; Kim JW; Ki CS
    Ann Clin Lab Sci; 2010; 40(3):290-4. PubMed ID: 20689144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mystery Case: Cutaneous lesions in KRIT1-associated cerebral cavernous malformations.
    Brownlee WJ; Roxburgh R
    Neurology; 2014 Sep; 83(14):e133-4. PubMed ID: 25267988
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous venous malformations related to KRIT1 mutation: case report and literature review.
    Grippaudo FR; Piane M; Amoroso M; Longo B; Penco S; Chessa L; Giubettini M; Santanelli F
    J Mol Neurosci; 2013 Oct; 51(2):442-5. PubMed ID: 23828392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral cavernous malformation: clinical report of two families with variable phenotype associated with KRIT1 mutation.
    Balasubramanian M; Jain V; Glover RC; Robertson LK; Mordekar SR
    Eur J Paediatr Neurol; 2013 Nov; 17(6):661-5. PubMed ID: 23806994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.
    Guzeloglu-Kayisli O; Amankulor NM; Voorhees J; Luleci G; Lifton RP; Gunel M
    Neurosurgery; 2004 Apr; 54(4):943-9; discussion 949. PubMed ID: 15046662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.
    Zhang J; Clatterbuck RE; Rigamonti D; Chang DD; Dietz HC
    Hum Mol Genet; 2001 Dec; 10(25):2953-60. PubMed ID: 11741838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of a novel inheritable CCM1 gene mutation of 671del AT in a Chinese family with cerebral cavernous malformation].
    Mao Y; Zhao Y; Zhou LF; Huang CX; Shou XF; Gong JL
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1572-5. PubMed ID: 14642111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene symbol: CCM2. Disease: Cerebral Cavernous Malformations.
    Jiménez-Huete A
    Hum Genet; 2008 Oct; 124(3):293. PubMed ID: 18846607
    [No Abstract]   [Full Text] [Related]  

  • 37. Large Cystic Cavernous Malformation in Infant with Novel KRIT1 Gene Abnormality.
    Lu VM; Daniels DJ
    World Neurosurg; 2019 Oct; 130():304-305. PubMed ID: 31326642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel CCM1 mutation in a patient with paraparesis and thoracic cord cavernous malformation.
    Waters MF; Shields DC; Martin NA; Baloh RW; Jen JC
    Neurology; 2005 Sep; 65(6):966-7. PubMed ID: 16186553
    [No Abstract]   [Full Text] [Related]  

  • 39. Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.
    Labauge P; Krivosic V; Denier C; Tournier-Lasserve E; Gaudric A
    Arch Ophthalmol; 2006 Jun; 124(6):885-6. PubMed ID: 16769843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute pediatric facial nerve paralysis as the first indication for familial cerebral cavernoma: case presentation and literature review.
    Rohani P; McRackan TR; Aulino JM; Wanna GB
    Am J Otolaryngol; 2014; 35(2):211-4. PubMed ID: 24156886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.